Patrick Griffin

A celebrated artist's 100-masterpiece donation funds patriotic education in Hong Kong, revealing a powerful alliance between art, business, and soft power.

A Chinese dance drama fusing martial arts and contemporary dance earns global acclaim, bridging cultural divides from Shenzhen to its sold-out Toronto debut.

Riding a wave of record sales from its iDose TR implant, Glaukos is set to update investors on its explosive growth and the launch of its new drug, Epioxa.

Canadian explorer 1911 Gold upgrades to OTC's top market, boosting visibility to U.S. investors as it advances its True North Gold Project restart.

While some public services face cuts, a Colorado library is expanding. We explore the strategy behind this counter-trend investment in community.

A new partnership claims to power an AI with meditated 'love' from at-risk communities. Is this a bold new paradigm or a controversial social experiment?

GrantWatch founder Libby Hikind is trading grant databases for picture books. Discover the strategy behind her pivot to value-driven children's literature.

Tech Mahindra's Global Chess League is partnering with AWS, using AI and smart broadcasting to transform the ancient game into a high-tech spectator sport.

A new startup is betting a premium AI desktop calendar can cure our smartphone addiction. But is another screen really the answer to too much screen time?

A new partnership in water controls reveals a masterclass in business strategy: leveraging a 70-year-old local agency for deep market penetration.

Dialed Moods' new sea moss and shilajit gummies enter a booming market. But do the ancient ingredients and modern science justify the industry's latest rush?

Austria’s famed Flying Bulls bring two historic aircraft to the US for one show only. A deep dive into the business of heritage and a transatlantic feat.

With $150M from Crayhill Capital, Rostrum Pacific isn't just buying music history—it's building an integrated ecosystem to redefine its future.

As enterprise AI projects falter, Vectara's new Tool Validator aims to fix AI agent errors before they happen, restoring trust and unlocking ROI.

JetBlue is opening its first lounge, BlueHouse. It's more than an amenity; it's a strategic pivot to capture premium flyers and redefine its brand.

Astellas Pharma's new deal with venture studio Autobahn Labs isn't just a partnership; it's a strategic overhaul of the R&D pipeline. Here's why.

A landmark UK study reveals an AI diagnostic tool that predicts heart attacks with stunning accuracy and offers a £25 million lifeline to strained health budgets.

With a massive lodge expansion and an all-inclusive dining plan, the cruise line is making a strategic play to dominate the lucrative Alaska land-tour market.

How a super-regional insurer's full-scale cloud modernization with Guidewire is a strategic move to boost agility and precision in challenging markets.

A seizure of fake Viagra at a Toronto convenience store reveals the dangerous shadow economy of counterfeit drugs threatening public health and business integrity.